Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18

Cytokine. 1999 Nov;11(11):822-30. doi: 10.1006/cyto.1999.0501.

Abstract

We investigated the effects of IL-12 and IL-18 on unstimulated murine splenocytes and observed that the two cytokines strongly synergized for their proliferation, whereas IL-12 and IL-18 alone were essentially inactive in this respect. Phenotypical and functional analyses of cells proliferating in response to IL-12 and IL-18 revealed that large granular Ly-49C(+)DX5(+)CD3(-)NK blasts were expanded in these cultures and that they displayed cytotoxic activity against Yac-1 cells, a murine NK cell target. Further analyses indicated three major differences between NK cells appearing in response to IL-12 and IL-18 and those derived in the presence of other NK cell growth factors, such as IL-2 or IL-15. First, a population of T-NK cells, i.e. expressing T cell (TCRalphabeta, CD3) and NK cell (Ly-49) markers, was detected amongst cells growing in IL-2 or IL-15 but not in cultures supplemented with IL-12 and IL-18. Second, most NK cells derived with IL-2 or IL-15 expressed the NK1.1 antigen, while those derived with IL-12 and IL-18 did not. Finally, striking differences were observed regarding cytokine production. Cells stimulated with IL-12 and IL-18 in combination, but not with IL-2 or IL-15, produced IFN-gamma, IL-3, IL-6 and TNF. IFN-gamma was not involved in the response of NK cells to IL-12 and IL-18, as indicated by experiments demonstrating that the combination of the two cytokines displayed similar effects on spleen cells from IFN-gammaR-knock-out mice. Receptor (IL-12Rbeta1, IL-12Rbeta2 and IL-18R) gene expression studies did not indicate that the mechanism underlying the synergy between IL-12 and IL-18 involved reciprocal induction of their receptors. Taken together, our results demonstrate that IL-12 and IL-18 exert striking synergistic activities for NK cell proliferation and activation, distinct from those induced by IL-2 or IL-15.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Surface / metabolism
  • Cell Division / drug effects
  • Cells, Cultured
  • Cytokines / biosynthesis
  • Drug Synergism
  • Flow Cytometry
  • Gene Expression / drug effects
  • Immunophenotyping
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / genetics
  • Interferon-gamma / pharmacology
  • Interferon-gamma / physiology
  • Interleukin-12 / genetics
  • Interleukin-12 / pharmacology*
  • Interleukin-15 / pharmacology
  • Interleukin-18 / genetics
  • Interleukin-18 / pharmacology*
  • Interleukin-18 Receptor alpha Subunit
  • Interleukin-2 / pharmacology
  • Killer Cells, Natural / cytology
  • Killer Cells, Natural / drug effects*
  • Killer Cells, Natural / metabolism
  • Lymphocyte Activation / drug effects
  • Mice
  • Mice, Knockout
  • Receptors, Interleukin / biosynthesis
  • Receptors, Interleukin / genetics
  • Receptors, Interleukin-12
  • Receptors, Interleukin-18
  • Spleen / cytology
  • Spleen / drug effects

Substances

  • Antigens, Surface
  • Cytokines
  • Il18r1 protein, mouse
  • Interleukin-15
  • Interleukin-18
  • Interleukin-18 Receptor alpha Subunit
  • Interleukin-2
  • Receptors, Interleukin
  • Receptors, Interleukin-12
  • Receptors, Interleukin-18
  • Interleukin-12
  • Interferon-gamma